141 related articles for article (PubMed ID: 22022327)
21. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
22. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
23. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
[TBL] [Abstract][Full Text] [Related]
24. Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model.
Sun J; Bao J; Shi Y; Zhang B; Yuan L; Li J; Zhang L; Sun M; Zhang L; Sun W
Int J Chron Obstruct Pulmon Dis; 2017; 12():717-724. PubMed ID: 28260878
[TBL] [Abstract][Full Text] [Related]
25. Effect of small hairpin RNA targeting endothelin-converting enzyme-1 in monocrotaline-induced pulmonary hypertensive rats.
Son JS; Kim KC; Kim BK; Cho MS; Hong YM
J Korean Med Sci; 2012 Dec; 27(12):1507-16. PubMed ID: 23255850
[TBL] [Abstract][Full Text] [Related]
26. The effect of sildenafil on right ventricular remodeling in a rat model of monocrotaline-induced right ventricular failure.
Bae HK; Lee H; Kim KC; Hong YM
Korean J Pediatr; 2016 Jun; 59(6):262-70. PubMed ID: 27462355
[TBL] [Abstract][Full Text] [Related]
27. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
28. Modafinil improves monocrotaline-induced pulmonary hypertension rat model.
Lee H; Kim KC; Cho MS; Suh SH; Hong YM
Pediatr Res; 2016 Jul; 80(1):119-27. PubMed ID: 26959484
[TBL] [Abstract][Full Text] [Related]
29. Simvastatin protects against the development of monocrotaline-induced pulmonary hypertension in rats via a heme oxygenase-1-dependent pathway.
Zhang WH; Zhang YJ; Liu CP; Yu BX; Lu WX
Exp Lung Res; 2011 Oct; 37(8):492-9. PubMed ID: 21867382
[TBL] [Abstract][Full Text] [Related]
30. Propylthiouracil attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Sun CK; Yuen CM; Kao YH; Chang LT; Chua S; Sheu JJ; Yen CH; Ko SF; Yip HK
Circ J; 2009 Sep; 73(9):1722-30. PubMed ID: 19602776
[TBL] [Abstract][Full Text] [Related]
31. Exploration of the Notch3-HES5 signal pathway in monocrotaline-induced pulmonary hypertension using rat model.
Chen X; Zhou W; Hu Q; Huang L
Congenit Heart Dis; 2019 May; 14(3):396-402. PubMed ID: 30811836
[TBL] [Abstract][Full Text] [Related]
32. Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Yip HK
Circ J; 2008 May; 72(5):825-31. PubMed ID: 18441466
[TBL] [Abstract][Full Text] [Related]
33. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
34. [Changes of MMP-2,9 and TIMP-1 expressions in rats with pulmonary arterial hypertension after captopril and losartan interventions].
Wang XM; Zhou TF; Liu B; Wei L; Shi K; Zhao SS; Hua YM; Liu HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):255-9. PubMed ID: 19462901
[TBL] [Abstract][Full Text] [Related]
35. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
Satoh M; Satoh A
J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
[TBL] [Abstract][Full Text] [Related]
36. Combination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats.
Kuang T; Wang J; Pang B; Huang X; Burg ED; Yuan JX; Wang C
Pulm Pharmacol Ther; 2010 Oct; 23(5):456-64. PubMed ID: 20188205
[TBL] [Abstract][Full Text] [Related]
37. Association between endothelial function and micro-vascular remodeling measured by synchrotron radiation pulmonary micro-angiography in pulmonary arterial hypertension.
Fuji S; Matsushita S; Hyodo K; Osaka M; Sakamoto H; Tanioka K; Miyakawa K; Kubota M; Hiramatsu Y; Tokunaga C
Gen Thorac Cardiovasc Surg; 2016 Oct; 64(10):597-603. PubMed ID: 27393332
[TBL] [Abstract][Full Text] [Related]
38. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
Rakotoniaina Z; Guerard P; Lirussi F; Rochette L; Dumas M; Goirand F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):241-51. PubMed ID: 18542928
[TBL] [Abstract][Full Text] [Related]
39. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
[TBL] [Abstract][Full Text] [Related]
40. Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
Fontoura D; Oliveira-Pinto J; Tavares-Silva M; Leite S; Vasques-Nóvoa F; Mendes-Ferreira P; Lourenço AP; Leite-Moreira AF
Rev Port Cardiol; 2014 Apr; 33(4):213-22. PubMed ID: 24780128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
